Isolated Limb Infusion and Isolated Limb Perfusion for Melanoma: Can the Outcomes of these Procedures be Compared?

[1]  R. Emerson,et al.  Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade , 2018, Cancer Immunology Research.

[2]  B. Coventry,et al.  Isolated Limb Infusion for Recurrent and Locally Metastatic Limb Melanoma , 2018 .

[3]  B. Coventry,et al.  Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter Study , 2017, Annals of Surgical Oncology.

[4]  M. Wouters,et al.  Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients , 2017, Annals of Surgical Oncology.

[5]  Lesly A. Dossett,et al.  Clinical Response and Regional Toxicity Following Isolated Limb Infusion Compared with Isolated Limb Perfusion for In-Transit Melanoma , 2016, Annals of Surgical Oncology.

[6]  C. Verhoef,et al.  Perfusion and infusion for melanoma in-transit metastases in the era of effective systemic therapy. , 2015, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[7]  A. Testori,et al.  Local and intralesional therapy of in‐transit melanoma metastases , 2011, Journal of surgical oncology.

[8]  C. Augustine,et al.  Current trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institution. , 2011, Journal of the American College of Surgeons.

[9]  P. Kam,et al.  Isolated limb perfusion and isolated limb infusion for malignant lesions of the extremities. , 2011, Current problems in surgery.

[10]  L. de la Cruz-Merino,et al.  Isolated limb perfusion for malignant melanoma: systematic review on effectiveness and safety. , 2010, The oncologist.

[11]  R. Petersen,et al.  Isolated Limb Infusion for In-Transit Malignant Melanoma of the Extremity: A Well-Tolerated but Less Effective Alternative to Hyperthermic Isolated Limb Perfusion , 2008, Annals of Surgical Oncology.

[12]  P. Kam,et al.  Outcomes Following Isolated Limb Infusion for Melanoma. A 14-Year Experience , 2008, Annals of Surgical Oncology.

[13]  J. Zager,et al.  Toxicities associated with hyperthermic isolated limb perfusion and isolated limb infusion in the treatment of melanoma and sarcoma , 2008, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[14]  B. Etten,et al.  Fifty Tumor Necrosis Factor–Based Isolated Limb Perfusions for Limb Salvage in Patients Older Than 75 Years With Limb-Threatening Soft Tissue Sarcomas and Other Extremity Tumors , 2003, Annals of Surgical Oncology.

[15]  A. Eggermont,et al.  Systemic toxicity after isolated limb perfusion with melphalan for melanoma. , 1996, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.